$TEVA Market Cap:
Research Board Inbox Deep Research Not Interested Shortlisted

$TEVA SEC Filings

Filing Filed On
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K 27 Jul 2010
REGISTRATION STATEMENT 27 Jul 2010
TEVA COMMENTS ON GENERIC LOVENOX? APPROVAL 26 Jul 2010
NOTICE 20 Jul 2010
TEVA PROVIDES UPDATE ON GENERIC PROTONIX? LITIGATION 20 Jul 2010
TEVA INTRODUCES FIRST GENERIC EFFEXOR XR? CAPSULES IN THE UNITED STATES; AWARDED 01 Jul 2010
NOTICE ON THE ANNUAL GENERAL MEETING 30 Jun 2010
TEVA ANNOUNCES LAUNCH OF GENERIC ARIMIDEX? 29 Jun 2010
TEVA ANNOUNCES APPROVAL OF GENERIC EFFEXOR XR? 29 Jun 2010
TEVA ANNOUNCES COMPLETION OF $2.5 BILLION OF SENIOR NOTES OFFERING 21 Jun 2010
FORM 6-K 18 Jun 2010
TEVA ANNOUNCES PRICING OF $2.5 BILLION OF SENIOR NOTES 17 Jun 2010
FREE WRITING PROSPECTUS 16 Jun 2010
FINAL PROSPECTUS SUPPLEMENT 16 Jun 2010
PROSPECTUS SUPPLEMENT 15 Jun 2010
FORM 6-K 15 Jun 2010
TEVA ANNOUNCES LAUNCH OF GENERIC DIFFERIN? 03 Jun 2010
CORRESP 02 Jun 2010
CORRESP 02 Jun 2010
TEVA ANNOUNCES LAUNCH OF GENERIC YAZ? TABLETS 01 Jun 2010